Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M106955200 on January 11, 2002

J. Biol. Chem., Vol. 277, Issue 12, 10427-10434, March 22, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/12/10427    most recent
M106955200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holm, P. S.
Right arrow Articles by Royer, H.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holm, P. S.
Right arrow Articles by Royer, H.-D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

YB-1 Relocates to the Nucleus in Adenovirus-infected Cells and Facilitates Viral Replication by Inducing E2 Gene Expression through the E2 Late Promoter*

Per S. HolmDagger §, Stephan Bergmann||**, Karsten Jürchott||, Hermann Lage§, Karsten Brand||, Axel Ladhoff§, Klaus MantwillDagger , David T. CurielDagger Dagger , Matthias Dobbelstein§§, Manfred Dietel§, Bernd GänsbacherDagger , and Hans-Dieter Royer||¶¶

From the Dagger  Institut für Experimentelle Onkologie und Therapieforschung, Technische Universität München, Klinikum Rechts der Isar, München 81675, Germany, the § Institut für Pathologie, Universitätsklinikum Charité, Humboldt-Universität zu Berlin, Berlin 10117, Germany, the || Max-Delbrück Zentrum für Molekulare Medizin, Berlin 13125, Germany, the §§ Institut für Virologie, Philipps-Universität Marburg, Marburg 35037, Germany, the ¶¶ Institut für Transplantationsdiagnostik und Zelltherapeutika and the ** Institut für Humangenetik und Anthropologie, Heinrich-Heine Universität Düsseldorf, Düsseldorf 40225, Germany, and the Dagger Dagger  Gene Therapy Program, University of Alabama at Birmingham, Wallace Tumor Institute, Birmingham, Alabama 352948

The adenovirus early proteins E1A and E1B-55kDa are key regulators of viral DNA replication, and it was thought that targeting of p53 by E1B-55kDa is essential for this process. Here we have identified a previously unrecognized function of E1B for adenovirus replication. We found that E1B-55kDa is involved in targeting the transcription factor YB-1 to the nuclei of adenovirus type 5-infected cells where it is associated with viral inclusion bodies believed to be sites of viral transcription and replication. We show that YB-1 facilitates E2 gene expression through the E2 late promoter thus controlling E2 gene activity at later stages of infection. The role of YB-1 for adenovirus replication was demonstrated with an E1-minus adenovirus vector containing a YB-1 transgene. In infected cells, AdYB-1 efficiently replicated and produced infectious progeny particles. Thus, adenovirus E1B-55kDa protein and the host cell factor YB-1 act jointly to facilitate adenovirus replication in the late phase of infection.

* This work was supported by Grant Ho 1482/2-2 from the Deutsche Forschungsgemeinschaft (to P. S. H.) and by a Berliner Krebsgesellschaft grant (to H.-D. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Institut für Experimentelle Onkologie und Therapie, Technische Universität München, Klinikum Rechts der Isar, Ismaningerstrasse 22, München 81675, Germany. Tel.: 49-89-4140-4452; Fax: 49-89-4140-4476; E-mail: per.s.holm@lrz.tum.de.

Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
A. E. Tollefson, B. Ying, K. Doronin, P. D. Sidor, and W. S. M. Wold
Identification of a New Human Adenovirus Protein Encoded by a Novel Late l-Strand Transcription Unit
J. Virol., December 1, 2007; 81(23): 12918 - 12926.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. To, Y. Zhao, H. Jiang, K. Hu, M. Wang, J. Wu, C. Lee, D. W. Yokom, A. L. Stratford, U. Klinge, et al.
The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor
Mol. Pharmacol., September 1, 2007; 72(3): 641 - 652.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Mantwill, N. Kohler-Vargas, A. Bernshausen, A. Bieler, H. Lage, A. Kaszubiak, P. Surowiak, T. Dravits, U. Treiber, R. Hartung, et al.
Inhibition of the Multidrug-Resistant Phenotype by Targeting YB-1 with a Conditionally Oncolytic Adenovirus: Implications for Combinatorial Treatment Regimen with Chemotherapeutic Agents.
Cancer Res., July 15, 2006; 66(14): 7195 - 7202.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. Glockzin, K. Mantwill, K. Jurchott, A. Bernshausen, A. Ladhoff, H.-D. Royer, B. Gansbacher, and P. S. Holm
Characterization of the Recombinant Adenovirus Vector AdYB-1: Implications for Oncolytic Vector Development.
J. Virol., April 1, 2006; 80(8): 3904 - 3911.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. Tsapara, K. Matter, and M. S. Balda
The Heat-Shock Protein Apg-2 Binds to the Tight Junction Protein ZO-1 and Regulates Transcriptional Activity of ZONAB
Mol. Biol. Cell, March 1, 2006; 17(3): 1322 - 1330.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. I. Young, E. P. Hong, J. C. Castle, J. Crespo-Barreto, A. B. Bowman, M. F. Rose, D. Kang, R. Richman, J. M. Johnson, S. Berget, et al.
Inaugural Article: Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2
PNAS, December 6, 2005; 102(49): 17551 - 17558.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. R.C. van Roeyen, F. Eitner, S. Martinkus, S. R. Thieltges, T. Ostendorf, D. Bokemeyer, B. Luscher, J. M. Luscher-Firzlaff, J. Floege, and P. R. Mertens
Y-Box Protein 1 Mediates PDGF-B Effects in Mesangioproliferative Glomerular Disease
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2985 - 2996.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
O. V. Skabkina, D. N. Lyabin, M. A. Skabkin, and L. P. Ovchinnikov
YB-1 Autoregulates Translation of Its Own mRNA at or prior to the Step of 40S Ribosomal Subunit Joining
Mol. Cell. Biol., April 15, 2005; 25(8): 3317 - 3323.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. H. Thorne, G. Brooks, Y.-L. Lee, T. Au, L. F. Eng, and T. Reid
Effects of Febrile Temperature on Adenoviral Infection and Replication: Implications for Viral Therapy of Cancer
J. Virol., January 1, 2005; 79(1): 581 - 591.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. S. Holm, H. Lage, S. Bergmann, K. Jurchott, G. Glockzin, A. Bernshausen, K. Mantwill, A. Ladhoff, A. Wichert, J. S. Mymryk, et al.
Multidrug-resistant Cancer Cells Facilitate E1-independent Adenoviral Replication: Impact for Cancer Gene Therapy
Cancer Res., January 1, 2004; 64(1): 322 - 328.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Jurchott, S. Bergmann, U. Stein, W. Walther, M. Janz, I. Manni, G. Piaggio, E. Fietze, M. Dietel, and H.-D. Royer
YB-1 as a Cell Cycle-regulated Transcription Factor Facilitating Cyclin A and Cyclin B1 Gene Expression
J. Biol. Chem., July 18, 2003; 278(30): 27988 - 27996.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. P. Nekrasov, M. P. Ivshina, K. G. Chernov, E. A. Kovrigina, V. M. Evdokimova, A. A. M. Thomas, J. W. B. Hershey, and L. P. Ovchinnikov
The mRNA-binding Protein YB-1 (p50) Prevents Association of the Eukaryotic Initiation Factor eIF4G with mRNA and Inhibits Protein Synthesis at the Initiation Stage
J. Biol. Chem., April 11, 2003; 278(16): 13936 - 13943.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
E. Grinstein, P. Wernet, P. J.F. Snijders, F. Rosl, I. Weinert, W. Jia, R. Kraft, C. Schewe, M. Schwabe, S. Hauptmann, et al.
Nucleolin as Activator of Human Papillomavirus Type 18 Oncogene Transcription in Cervical Cancer
J. Exp. Med., October 21, 2002; 196(8): 1067 - 1078.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement